Methods We analysed two cohorts containing 897 patients with ‘pure’ systemic lupus erythematosus (SLE), rheumatoid arthritis ... scleroderma (including CREST syndrome, morphoea and linear scleroderma) ...

Systemic lupus can be mild or severe. Cutaneous lupus erythematosus This form of lupus is limited to the skin and can cause many types of rashes and lesions. Drug-induced lupus erythematosus This is a ...

Systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD, a group of intestinal disorders that cause inflammation of the digestive tract) share a common set of microbiome features that ...

In milder cases this can be accomplished by relatively simple means: a limited cutaneous rash may be ... Minimize both damage due to systemic lupus erythematosus and as consequence of medications ...

The patient is a 47-year-old male with a 6-year history of systemic lupus erythematosus (SLE ... It is thought that the cutaneous symptoms and vestibular symptoms are directly related to ...

The drug is being tested in patients with the most common form of lupus, systemic lupus erythematosus, where the patient's immune system attacks the body's own tissues and potentially leads to ...

a kidney disease-related complication of systemic lupus erythematosus. Patients were dosed with either 30 mg of zetomipzomib, 60 mg of zetomipzomib or placebo and standard background therapy.

Researchers found that among those patients affected by autoimmune skin diseases such as dermatomyositis (DM) and cutaneous lupus erythematosus (CLE), the use of herbal supplements is widespread. A ...

The Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) drugs in development market research report provides comprehensive information on the therapeutics under ...

Objective To assess the efficacy of anifrolumab, a type-1 interferon receptor subunit-1 monoclonal antibody, in treating refractory cutaneous lupus erythematosus (CLE) and lupus non-specific ...